Keywords: viagene, hiv-it, phase, ii, trials, company, focuses

Viagene's HIV-IT(V) In Phase II Trials

Article | 19 December 1994

Print This

US company Viagene, which focuses on developing gene therapy products for marketing by commercial partners, has begun Phase II trials ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in